Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595621 · ClinicalTrials.gov registry record · NA
Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT00595621 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 22 participants.
The verdict
NCT00595621, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Investigate the safety and efficacy of multi-channel gastric electrical stimulation in the treatment of patients with severe diabetic gastroparesis refractory to standard therapy.
Interventions
- DEVICE Enterra Multi-Channel Phased Gastric Pacemaker (MGP-1)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00595621
The ClinicalTrials.gov registry entry for NCT00595621 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enterra Multi-Channel Phased Gastric Pacemaker (MGP-1) is the first listed.
NCT00595621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00595621 about?
NCT00595621 is a clinical study titled "Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis". Investigate the safety and efficacy of multi-channel gastric electrical stimulation in the treatment of patients with severe diabetic gastroparesis refractory to standard therapy.
What is the current status of trial NCT00595621?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2006-02. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00595621?
The interventions under investigation include: Enterra Multi-Channel Phased Gastric Pacemaker (MGP-1) (DEVICE).
Who is sponsoring clinical trial NCT00595621?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.